InvestorsHub Logo

anfla

07/03/20 11:56 AM

#284400 RE: HinduKush #284388

I’m not talking about Amarin - the previous post was suggesting generics was to get the precedent from this case to invalidate more patents. But I was suggesting that’s not the case since most new drugs have more protection